|
1. Recipient of the John S. Schlesinger
Surgery Prize. Used for travel expenses to accept post in
London, 1979‑1980.
Projects completed there:
1. A correlation of the
pathology of carcinoma of the larynx with pre‑operative computed
tomography (CT) scans (Published).
2. Histological
examination of the pathological laryngeal specimen by a new
method (Published).
3. Respiratory function
tests in the laryngectomee, correlated with stomal size
(Published).
2. The use of the Pectoralis Major Myocutaneous Flap for the
reconstruction of patients after major ablative cancer surgery
(Published).
3. Carcinoma of the Larynx: particular reference to cartilage
invasion by cancer, and computed tomography of the larynx.
Study and thesis for PhD (Med) degree. Defended July 1986.
Grants from the S.A. Cancer Association, numbers RE6661 450577
and ME 6670 253599.
Supervisors for PhD. Professor D. Haynes (deceased, previous
Professor and Head of Otolaryngology, Wits University) and
Professor James Murray (deceased, previous Director, the South
African Institute for Medical Research, Johannesburg).
Graduated PhD degree, University of The Witwatersrand,
Johannesburg. Dec. 3, 1987.
4. The use of the Blom‑Singer voice restoration prosthesis in
laryngectomised patients. Recipient of grant from S.A. Cancer
Association.(Ref. CS 2588, 16 August, 1982)
5. The use of pre‑operative chemotherapy and radiation therapy
in the management of advanced squamous carcinoma of the head and
neck (Mitomycin-C and 5-fluoro-uracil). Phase I study completed,
1983.
6. The use of the Trapezius osteomyocutaneous flap for the
reconstruction of the mandible after ablative cancer surgery
(Published).
7. The use of the Laser in the management of patients with
laryngo‑tracheal stenosis (Published).
8. The value of the Flow‑Volume loop in the assessment of
treatment results in laryngo‑tracheal reconstruction
(published).
9. Supraglottic Laryngeal Cancer - a 10 year study in the
Netherlands Cancer Institute; Radiation and supraglottic
laryngectomy (published).
10. The use of the PROVOX® voice rehabilitation system in voice
rehabilitation in post-laryngectomised patients (published).
11. The management of neck disease in supraglottic cancer.
(Published)
12. The optimal construction of and the revision of the
tracheostoma with particular reference to voice rehabilitation.
(Published)
13. The treatment of small head and neck primary cancers with
primary radiation with neck dissection for the nodal disease.
(Published)
14. The use of SPECT scanning with 201Tl in head and neck
cancer. Started study in Amsterdam (2 publications). Ongoing
study at University of Stellenbosch, Vermaak B, Vlantis A,
Ellman A & Gregor, RT.
15. Control of postlaryngectomy pharyngo-oesophageal spasm in
obtaining good speech rehabilitation: a prospective analysis of
two types of pharyngeal repair at laryngectomy. Louw W & Gregor
RT.
16. Chemotherapy in nasopharyngeal carcinoma. Review: De
Villiers E, Vernimmen F & Gregor, RT.
17. US-FNA in assessing cervical metastases in head and neck
cancer. Knappe M & Gregor, RT
18. US in diagnosing local spread of cancer of the larynx or
hypopharynx. Knappe M & Gregor, RT
19. The use of laser resection plus active neck management in
larger tumours of the larynx and hypopharynx. (After Wolfgang
Steiner, Göttingen, Germany). Penning R, Lehmann K & Gregor, RT.
20. The use of the second generation PROVOX prosthesis
(PROVOX-2®) in patients previously rehabilitated with
non-indwelling prostheses. Oudes M, Elliot M, Vlantis A & Gregor
RT.
21. The use of Mitomycin-C in reducing fibrosis in
laryngotracheal stenosis surgery. Laser and open approaches.
Rzepecka O, Mansab Z & Gregor, RT
22. Investigation of P53 mutation in Head and Neck Cancer in SA,
a pilot study. Lehmann K and Gregor, RT
23. Localisation of sentinel nodes in supraglottic carcinomas.
Pentz A & Gregor, RT.
24. Multicentre Trial: Comparison of IA Chemoradiation with IV
Chemoradiation in advanced H&N Cancer. Principle investigator,
Waikato Hospital. Main contributor: The Dutch National Cancer
Institution (NKI) Amsterdam, The Netherlands. Trial completed
end of 2005.
25. Prognostic markers in squamous cell carcinoma of the head
and neck, Indu Gunawardena, Michael Jameson, Duncan Lamont,
Gregor, RT |
